Supply of new corona vaccine "biased to developed countries" Analysis by an international NGO September 19, 8:27
After the analysis that the supply of the new coronavirus vaccine, which is undergoing clinical trials, is expected to be biased toward developed countries, the NGOs investigated are calling on the governments of each country to take measures to ensure that the vaccine is distributed fairly to the world.
Based on data from a research firm, the international NGO Oxfam has analyzed which countries the five vaccines in clinical trials are expected to be supplied to.
According to the report, the total amount of vaccine to be supplied when all clinical trials are successful is more than 5.9 billion times, which is equivalent to about 2.9 billion people in the world when one person inoculates twice.
Of these, about 5.3 billion doses have been decided to be supplied to, and 51%, or 2.7 billion doses, will be supplied to developed countries such as the United States, the United Kingdom, and Japan.
NGOs have argued that regional disparities are widespread, saying that "13% of the world's richest countries will buy more than half of their vaccines."
In addition, we are calling on governments to take measures to ensure the fair distribution of vaccines to the world.